Nuclear β-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma

Human Pathology

Volumn 37, Issue 6, 2006, Pages 689-697

  Saito, Tsuyoshi ^a   Oda, Yoshinao ^a   Yamamoto, Hidetaka ^a   Kawaguchi, Ken ichi ^a   Tanaka, Kazuhiro ^a   Matsuda, Shuichi ^a   Iwamoto, Yukihide ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

catenin, cyclin D1; Epithelial mesenchymal transition; Pleomorphic sarcoma; Snail; Spindle cell sarcoma; Synovial sarcoma; Wnt signal

Indexed keywords

BETA CATENIN; CYCLIN D1; MESSENGER RNA; WNT PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CORRELATION ANALYSIS; EXON; GENE CLUSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOSIS; MUTATIONAL ANALYSIS; PLEOMORPHIC SARCOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA; SPINDLE CELL; SPINDLE SARCOMA; SYNOVIAL SARCOMA; TRANSCRIPTION INITIATION; TUMOR GROWTH;

BETA CATENIN; CELL NUCLEUS; CYCLIN D1; HUMANS; IMMUNOHISTOCHEMISTRY; RNA, MESSENGER; SARCOMA; SARCOMA, SYNOVIAL; TISSUE DISTRIBUTION;

EID: 33745454527     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.01.017     Document Type: Article

References (42)

1. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153 (1998) 333-339
2. Morin P.J., Sparks A.B., Korinek V., et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275 (1997) 1787-1790
3. Iwao K., Nakamori S., Kameyama M., et al. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58 (1998) 1021-1026
4. Rimm D.L., Caca K., Hu G., Harrison F.B., and Fearon E.R. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 154 (1999) 325-329
5. Takayasu H., Horie H., Hiyama E., et al. Frequent deletions and mutations of the β-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin Cancer Res 7 (2001) 901-908
6. Koch A., Denkhaus D., Albrecht S., Leuschner I., von Schweinitz D., and Pietsch T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res 59 (1999) 269-273
7. Palacios J., and Gamallo C. Mutation in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 58 (1998) 1344-1347
8. Fukuchi T., Sakamoto M., Tsuda H., Maruyama K., Nozawa S., and Hirohashi S. β-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58 (1998) 3526-3528
9. Zurawel R.H., Chiappa S.A., Allen C., and Raffel C. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 58 (1998) 896-899
10. Voeller H.J., Truica C.I., and Gelmann E.P. Beta-catenin mutations in human prostate cancer. Cancer Res 58 (1998) 2520-2523
11. Miyoshi Y., Iwao K., Nagasawa Y., et al. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58 (1998) 2524-2527
12. Chan E.F., Gat U., McNiff J.M., and Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 4 (1999) 410-413
13. Saito T., Oda Y., Tanaka K., et al. β-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumors. J Pathol 195 (2001) 222-228
14. Satoh S., Daigo Y., Furukawa Y., et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24 (2000) 245-250
15. Brabletz T., Jung A., Dag S., Hlubek F., and Kirchner T. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155 (1999) 1033-1038
16. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., et al. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumor. Oncogene 18 (1999) 2883-2891
17. He T.C., Sparks A.B., Rago C., et al. Identification of c-myc as a target of the APC pathway. Science 281 (1998) 1509-1512
18. Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
19. Saito T., Oda Y., Sakamoto A., et al. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of β-catenin mutations in synovial sarcoma. J Pathol 192 (2000) 342-350
20. Kuhnen C., Herter P., Muller O., et al. β-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas. Mod Pathol 13 (2000) 1005-1013
21. Hasegawa T., Yokoyama R., Matsuno Y., Shimoda T., and Hirohashi S. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol 32 (2001) 257-263
22. Ng T.L., Gown A.M., Barry T.S., et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 18 (2005) 68-74
23. Engellau J., Bendahl P.-O., Persson A., et al. Improved prognostification in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol 36 (2005) 994-1002
24. Kawai A., Woodruff J., Healey J.H., Brennan M.F., Antonescu C.R., and Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 338 (1998) 153-160
25. Antonescu C.R., Kawai A., Leung D.H., et al. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol 9 (2000) 1-8
26. Ladanyi M., Antonescu C.R., Leung D.H., et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62 (2002) 135-140
27. Saito T., Oda Y., Sugimachi K., et al. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. Am J Pathol 159 (2001) 2117-2124
28. Saito T., Oda Y., Kawaguchi K., et al. E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma. Oncogene 23 (2004) 8629-8638
29. Saito T., Oda Y., Kawaguchi K., et al. Possible association between higher β-catenin mRNA expression and mutated β-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction. Lab Invest 82 (2002) 97-103
30. Yagi O.K., Akiyama Y., Ohkura Y., et al. Analyses of the APC and TGF-β type II receptor genes, and microsatellite instability in mucosal colorectal carcinoma. Jpn J Cancer Res 88 (1997) 718-724
31. Saito T., Oda Y., Sakamoto A., et al. APC mutations in synovial sarcoma. J Pathol 16 (2002) 445-449
32. Sakamoto A., Oda Y., Adachi T., et al. β-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Arch Pathol Lab Med 126 (2002) 1071-1078
33. Ryo A., Nakamura M., Wulf G., Liou Y.C., and Lu K.P. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nat Cell Biol 3 (2001) 793-801
34. Cagatay T., and Ozturk M. p53 mutation is a source of aberrant β-catenin accumulation in cancer cells. Oncogene 21 (2002) 7971-7980
35. Nagayama S., Katagiri T., Tsunoda T., et al. Genome-wide analysis of gene expression in synovial sarcoma using cDNA microarray. Cancer Res 62 (2002) 5859-5866
36. Kim S.H., Lewis J.J., Brennan M.F., Woodruff J.M., Dudas M., and Cordon-Cardo C. Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas. Clin Cancer Res 4 (1998) 2377-2382
37. Antonescu C.R., Leung D.H., Dudas M., et al. Alterations of cell cycle regulators in localized synovial sarcoma: a multifactorial study with prognostic implications. Am J Pathol 156 (2000) 977-983
38. Saito T., Oda Y., Sakamoto A., Tamiya S., Iwamoto Y., and Tsuneyoshi M. Matrix metalloproteinase-2 expression correlates with morphological and immunohistochemical epithelial characteristics in synovial sarcoma. Histopathology 40 (2002) 279-285
39. Arias A.M. Epithelial mesenchymal interactions in cancer and development. Cell 105 (2001) 425-431
40. Kim K., Lu Z., and Hay E.D. Direct evidence for a role of β-catenin/Lef-1 signaling pathway in induction of EMT. Cell Biol Int 26 (2002) 463-476
41. Ueda Y., Hijikata M., Takagi S., et al. Wnt/β-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts. Int J Cancer 99 (2002) 681-688
42. Yang J., and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159 (2001) 1465-1475